JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishii, K.
Right arrow Articles by Schwaiger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishii, K.
Right arrow Articles by Schwaiger, M.
Journal of Nuclear Medicine Vol. 42 No. 4 548-557
© 2001 by Society of Nuclear Medicine


CLINICAL INVESTIGATIONS

Statistical Brain Mapping of 18F-FDG PET in Alzheimer’s Disease: Validation of Anatomic Standardization for Atrophied Brains

Kazunari Ishii, Frode Willoch, Satoshi Minoshima, Alexander Drzezga, Edward P. Ficaro, Donna J. Cross, David E. Kuhl and Markus Schwaiger

Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Germany; Department of Internal Medicine (Nuclear Medicine), University of Michigan, Ann Arbor, Michigan; and Department of Radiology, University of Washington Medical School, Seattle, Washington

Despite the increased use of statistical mapping to detect brain functional changes in Alzheimer’s disease (AD), potential artifacts introduced by stereotactic anatomic standardization of atrophied brains have not been examined carefully. We investigated the effects of anatomic standardization by Statistical Parametric Mapping (SPM) and NEUROSTAT. Methods: First, 10 AD patients and 10 age-matched healthy volunteers underwent 18F-FDG brain PET imaging. Each image set was standardized to a stereotactic brain template using SPM or NEUROSTAT, followed by pixel normalization to the global or cerebellar activity. Within-group comparisons of standardized image sets by each method and a between-group comparison of healthy volunteers and AD patients were performed using the statistical analysis routines of SPM. Second, simulated PET image sets were generated from segmented MR image sets of 5 healthy volunteers and 5 AD patients. Using the anatomic standardization parameters estimated on the simulated image sets, original gray matter MR image sets were transformed to the stereotactic coordinate system. Between-group subtraction analyses of the transformed gray matter image sets between healthy volunteers and AD groups were performed to examine the accuracy of cortical gray matter matching. Results: Between-group comparison by SPM or NEUROSTAT showed generally similar areas of hypometabolism in bilateral temporoparietal, posterior cingulate, and left frontal cortices. Both methods showed possible deformation artifacts in the anterior part of the corpus callosum. The localization of the peak hypometabolism varied considerably between the two methods when global normalization was applied. The use of a common brain template for standardization resulted in asymmetric differences in cortical margins, indicating systematic differences in the deformation algorithms. The realistic simulation study revealed gray matter mismatches to be 20% greater with SPM than with NEUROSTAT. Conclusion: Although different statistical mapping methods may yield grossly similar patterns of hypometabolism in AD, the extent, severity, and peak location of metabolic changes can be inconsistent. Deformation accuracy appears to be more prone to atrophy. These limitations need to be considered carefully in the application and interpretation of brain mapping analysis in atrophied brains.

Key Words: brain mapping • Alzheimer’s disease • PET




This article has been cited by other articles:


Home page
JNMHome page
L. Mosconi, W. H. Tsui, K. Herholz, A. Pupi, A. Drzezga, G. Lucignani, E. M. Reiman, V. Holthoff, E. Kalbe, S. Sorbi, et al.
Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
J. Nucl. Med., March 1, 2008; 49(3): 390 - 398.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
K HERHOLZ, S F CARTER, and M JONES
Positron emission tomography imaging in dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S160 - S167.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. L. Foster, J. L. Heidebrink, C. M. Clark, W. J. Jagust, S. E. Arnold, N. R. Barbas, C. S. DeCarli, R. Scott Turner, R. A. Koeppe, R. Higdon, et al.
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Brain, October 1, 2007; 130(10): 2616 - 2635.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Kas, P. Payoux, M.-O. Habert, Z. Malek, Y. Cointepas, G. El Fakhri, P. Chaumet-Riffaud, E. Itti, and P. Remy
Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images
J. Nucl. Med., September 1, 2007; 48(9): 1459 - 1467.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Matsuda
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
J. Nucl. Med., August 1, 2007; 48(8): 1289 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Matsuda, S. Mizumura, T. Nagao, T. Ota, T. Iizuka, K. Nemoto, N. Takemura, H. Arai, and A. Homma
Automated Discrimination Between Very Early Alzheimer Disease and Controls Using an Easy Z-Score Imaging System for Multicenter Brain Perfusion Single-Photon Emission Tomography
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 731 - 736.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Yin, N. Shuke, A. Okizaki, J. Sato, T. Aburano, Y. Li, S. Kaneko, M. Mizunaga, and S. Yachiku
Cerebral Activation During Withholding Urine with Full Bladder in Healthy Men Using 99mTc-HMPAO SPECT
J. Nucl. Med., July 1, 2006; 47(7): 1093 - 1098.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Drzezga, T. Grimmer, M. Riemenschneider, N. Lautenschlager, H. Siebner, P. Alexopoulus, S. Minoshima, M. Schwaiger, and A. Kurz
Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
J. Nucl. Med., October 1, 2005; 46(10): 1625 - 1632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. Takahashi, S. Yamaguchi, S. Kobayashi, and Y. Yamamoto
Effects of Aging on Regional Cerebral Blood Flow Assessed By Using Technetium Tc 99m Hexamethylpropyleneamine Oxime Single-Photon Emission Tomography with 3D Stereotactic Surface Projection Analysis
AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 2005 - 2009.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. L. Buckner, A. Z. Snyder, B. J. Shannon, G. LaRossa, R. Sachs, A. F. Fotenos, Y. I. Sheline, W. E. Klunk, C. A. Mathis, J. C. Morris, et al.
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
J. Neurosci., August 24, 2005; 25(34): 7709 - 7717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Sakamoto, K. Ishii, K. Hosaka, T. Mori, M. Sasaki, and E. Mori
Detectability of Hypometabolic Regions in Mild Alzheimer Disease: Function of Time after the Injection of 2-[Fluorine 18]-Fluoro-2-Deoxy-D-Glucose
AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 843 - 847.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Drzezga, M. Riemenschneider, B. Strassner, T. Grimmer, M. Peller, A. Knoll, S. Wagenpfeil, S. Minoshima, M. Schwaiger, and A. Kurz
Cerebral glucose metabolism in patients with AD and different APOE genotypes
Neurology, January 11, 2005; 64(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Hirono, M. Hashimoto, K. Ishii, H. Kazui, and E. Mori
One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, November 1, 2004; 16(4): 488 - 492.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Imabayashi, H. Matsuda, T. Asada, T. Ohnishi, S. Sakamoto, S. Nakano, and T. Inoue
Superiority of 3-Dimensional Stereotactic Surface Projection Analysis over Visual Inspection in Discrimination of Patients with Very Early Alzheimer's Disease from Controls Using Brain Perfusion SPECT
J. Nucl. Med., September 1, 2004; 45(9): 1450 - 1457.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Moretti, A. P. Lieberman, E. A. Wilde, B. I. Giordani, K. J. Kluin, R. A. Koeppe, S. Minoshima, D. E. Kuhl, W. K. Seltzer, and N. L. Foster
Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis
Neurology, May 25, 2004; 62(10): 1865 - 1868.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Hosoda, T. Kawaguchi, K. Ishii, S. Minoshima, Y. Shibata, M. Iwakura, S. Ishiguro, and E. Kohmura
Prediction of Hyperperfusion After Carotid Endarterectomy by Brain SPECT Analysis With Semiquantitative Statistical Mapping Method
Stroke, May 1, 2003; 34(5): 1187 - 1193.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. J. Van Laere, J. Warwick, J. Versijpt, I. Goethals, K. Audenaert, B. Van Heerden, and R. Dierckx
Analysis of Clinical Brain SPECT Data Based on Anatomic Standardization and Reference to Normal Data: An ROC-Based Comparison of Visual, Semiquantitative, and Voxel-Based Methods
J. Nucl. Med., April 1, 2002; 43(4): 458 - 469.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.